The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Relay Medical is evolving an integrated Medtech incubator/accelerator platform, which develops and productizes multiple products and projects concurrently and vets strategic acquisitions, that are complimentary to current infrastructure assets and investment thesis.
Revive Therapeutics Ltd. is a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products. The Company’s novel cannabinoid delivery technology is being advanced to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory and liver diseases.
RISE Life Science Corp. is currently developing and evolving medical and adult-use hemp-based formulations to create general use health and well-being products for the emerging consumer category made possible by the legalization of hemp in the United States pursuant to the Agricultural Improvement Act of 2018. The Company launched its CBD-based sexual wellness products in June 2018. The acquisition of Life Bloom Organics in July 2018 expanded RISE’s portfolio of CBD products from sexual health and wellness products to include general wellness and sleep products and provides access to Life Bloom’s existing channels of distribution and production in the United States and California in particular. RISE also leverages Life Bloom’s proprietary process of nanotizing CBD for increased bioavailability (without psychoactivity) in future products created under the RISE brand umbrella.
RMMI Corp. is an Alberta-based company focused on the production, cultivation and sale of medical marijuana in various forms. RMMI, through its wholly-owned subsidiary, Rocky Mountain is a late stage applicant under the Access to Cannabis for Medical Purposes Regulations and is in the process of obtaining the requisite license to commence cannabis production and operations. Rocky Mountain blends science with nature using aeroponic cultivation and CO2 extraction. Rocky Mountain intends to produce high-purity, organic-quality cannabis oils. Its team will employ leading, commercially-available science and technology to maximize production yields and product quality as a low-cost producer, while reducing risk to its crops and its business.
Rubicon Organics Inc. (the “Company”) is a North American company with operations in
Canada, California, and Washington. The Company was incorporated pursuant to the
Business Corporations Act (British Columbia) on May 15, 2015. The principal activity of
the Company is within the cannabis sector.
SLANG Worldwide is a leading cannabis-focused consumer packaged goods company. SLANG Worldwide is focused on acquiring and developing market-proven regional brands, as well as creating new brands to meet the needs of cannabis consumers worldwide.
SOL Global is an international investment company with a focus on, but not limited to, cannabis and cannabis related companies in legal U.S. states, the hemp and CBD marketplaces and the emerging European cannabis and hemp marketplaces. Its strategic investments and partnerships across cultivation, distribution and retail complement the company’s R&D program with the University of Miami. It is this comprehensive approach that is positioning SOL Global as a future front runner in the United States’ medical cannabis industry.
SpeakEasy is a late stage ACMPR applicant that is leveraging three generations of farming experience and the largest land package of LP in Canada with 290 acres of the best agricultural land in British Columbia’s Southern interior region; known as the Napa Valley of weed country. SpeakEasy is disrupting the cultivation model by aggregating Briitish Columbia’s best craft growers under one umbrella to produce the highest quality cannabis targeted at the highly sought after millennial recreational market.
SpeakEasy has submitted its extensive evidence package to Health Canada for its current 10,000 square feet facility and has commenced construction on its 80,000 square feet expansion facility. This 80,000 square foot facility will include growing, extraction and genetics labs that will be capable of producing more than 10,000 kg annually.
Sproutly’s core mission is to become the leading supplier to the cannabis beverage and edibles market. Our Toronto based, ACMPR licensed facility was built to cultivate pharmaceutical grade cannabis to supply a technological breakthrough in producing and formulating the first natural, truly water-soluble cannabis solution. Our water-soluble ingredients and our bio-natural oils will deliver revolutionary brands to international markets that are clamouring for well-defined commercial products. Sproutly’s business focus is to execute on partnerships with local and globally established consumer brands to leverage their existing customer bases, further expand brand loyalty, assist with marketing, and support distribution networks to deliver this scientific breakthrough with speed and efficiency worldwide.